Sale!

Riboksin (Inosine) 200 mg N50 – Stimulates Myocardial Metabolic Processes

(1 customer review)

11,49

RIBOKSIN (Inosine) stimulates myocardial metabolic processes; provides antihypoxic and antiarrhythmic action; increases myocardial energy balance; improves coronary circulation; prevents the consequences of intraoperative kidney ischemia; takes part in the process of glucose exchange; activates metabolism in hypoxic conditions; stimulates the synthesis of nucleotides. Provides anabolic effect. Riboxin slows down the destructive processes in the cardiomyocyte sarcolemma. It reduces the area of necrosis and myocardial ischemia by improving microcirculation. Riboxin is also considered to improve muscle development.

Availability: 40 in stock

Experience the Power of Riboksin: Your Metabolic Regulator

Introduction:

Riboksin is a remarkable medicinal product that falls under the category of medicines regulating metabolic processes. With its antihypoxic, metabolic, and antiarrhythmic actions, Riboksin provides a range of benefits. This powerful formulation works to enhance myocardial energy balance, improve coronary circulation, and prevent the consequences of intraoperative renal ischemia. By positively influencing exchange processes within the myocardium, increasing heart muscle strength, and promoting ultimate relaxation of the myocardium, Riboksin boosts strike output and contributes to overall cardiovascular health. Additionally, it reduces thrombocyte aggregation and stimulates tissue regeneration. Moreover, it is worth noting that Riboksin plays a crucial role in the well-being of the myocardium and gastrointestinal mucosa.

Effective for Patients with Diabetes Mellitus:

For patients with diabetes mellitus, it is important to note that one tablet of Riboksin corresponds to 0.00641 bread unit. This information allows individuals with diabetes to easily incorporate Riboksin into their treatment regimen while maintaining optimal blood sugar control.

Active Ingredient and Pharmaceutical Form:

The active substance in the product is inosine, also known as riboxin. It is available in the form of film-coated tablets, ensuring convenient and easy administration.

Indications for Use:

Riboksin is indicated for use in various conditions, including:
  • Ischemic heart disease in combination therapy
  • Post-myocardial infarction treatment
  • Heart rhythm disorders mediated by cardiac glycosides
Method of Administration:

It is taken orally, ideally before a meal. The recommended daily dose of Riboksin ranges from 0.6 to 2.4 grams. During the initial days of treatment, the daily dose starts at 0.6 to 0.8 grams, taken three to four times a day (200 mg per dose). If well-tolerated, the dose can be increased to 1.2 grams (0.4 grams three times a day) on days 2-3. If necessary, the maximum daily dose can be increased to 2.4 grams. The duration of treatment typically lasts between 4 weeks and 1.5 to 3 months, depending on the individual’s condition.

Effective Treatment for Urocoproporphyria:

In the case of urocoproporphyria, the recommended daily dose of Riboksin is 0.8 grams (200 mg four times a day). The treatment course for this condition usually lasts between 1 to 3 months.

Shelf Life and Expiry Date:

It has a shelf life of 3 years. It is essential not to use the product after the expiry date indicated on the packaging to ensure its effectiveness and safety.

Discover the Power:

It is a trusted medicinal product that regulates metabolic processes and provides essential support for various cardiovascular conditions. With its unique formulation and active ingredient, Riboksin optimizes myocardial energy balance, improves coronary circulation, and promotes tissue regeneration. Take control of your health and experience the benefits of Riboksin. Embrace a healthier future with Riboksin by your side

1 review for Riboksin (Inosine) 200 mg N50 – Stimulates Myocardial Metabolic Processes

  1. Sem

    Finally found it where to buy. Really good!

Add a review

Your email address will not be published. Required fields are marked *